Myelodysplastic Syndromes (MDS) Drug Market in China 2021
- Markverslag
- ID: HL10085C
- Afleweringstyd: 1 Werksdag
- Merk: Myelodysplastic Syndromes
Beskrywing
The myelodysplastic syndromes (MDS) drug market in China in terms of revenue is set to grow by US$ 548 miljoen tydens 2021-2027, groei teen 'n saamgestelde jaarlikse groeikoers (CAGR) van 17.3% gedurende die voorspellingsperiode, volgens die data- en ontledingsmaatskappy StrategyHelix.
Die verslag verskaf up-to-date markgrootte data vir tydperk 2017-2020 en voorspel tot 2027 covering key market aspects like sales value for myelodysplastic syndromes (MDS) drug. The China myelodysplastic syndromes (MDS) drug market is segmented on the basis of region. By region, it is categorized into Central South China, East China, North China, Northeast China, Northwest China, and Southwest China.
The report has profiled some of the key players of the market such as Ascentawits Pharmaceuticals Ltd., Bristol-Myers Squibb Company, Innovent Biologics Inc., Novartis International AG, Takeda Pharmaceutical Co. Bpk.
Die verslag is 'n waardevolle hulpbron vir maatskappye en organisasies wat in hierdie bedryf aktief is. It provides a cohesive picture of the myelodysplastic syndromes (MDS) drug market to help drive informed decision making for industry executives, beleidmakers, akademies, en ontleders.
Verslag Omvang
Streek: Central South China, East China, North China, Northeast China, Northwest China, and Southwest China
Jare oorweeg: hierdie verslag dek die tydperk 2017 aan 2027
Sleutelvoordele vir belanghebbendes
Get a comprehensive picture of the China myelodysplastic syndromes (MDS) drug market
Bepaal groeisektore en -neigings vir belegging
Understand what the future of the myelodysplastic syndromes (MDS) drug market in China looks like
Identifiseer die mededingende landskap en geleentheidsvenster
INHOUDSOPGAWE
1. Markdefinisie
2. Navorsingsmetodologie
3. Markdata & Outlook
3.1 Markwaarde
3.2 Markwaarde Voorspelling
4. Myelodysplastic Syndromes (MDS) Drug Market by Region
4.1 Central South China
4.2 East China
4.3 North China
4.4 Northeast China
4.5 Northwest China
4.6 Southwest China
5. Maatskappy profiele
5.1 Ascentawits Pharmaceuticals, Bpk.
5.2 Bristol-Myers Squibb Company
5.3 Innovent Biologics, Inc.
5.4 Novartis International AG
5.5 Takeda Pharmaceutical Co. Bpk.
6. Bylaag
6.1 Oor StrategyHelix
6.2 Vrywaring
USD 450